Skip navigation
MOST POPULAR RELATED TAGS
  • TOPICS
  • SECTORS
  • COMPANIES

MAD MONEY FEATURES

Podcasts PODCASTS
Watch the Lightning Round whenever and wherever you want.




Widget OFFICIAL MAD MONEY WIDGET
Grab this all-in-one application and get recaps of the show sent right to your desktop or blog.




Soundboard CRAMERS SOUNDBOARD
Admit it: You've always wanted to hit the "They
know nothing!" button. Here’s your chance.




Mad Money PhotosCHECK OUT OUR PHOTOS
Check out Cramer on set, back to school, behind the scenes and more.




ShopSHOP FOR MAD MERCHANDISE
Buy Cramer books, bobbleheads and other Mad Money merchandise.




Ringtones RING TONES
Pick up the phone! It's Cramer! New Mad Money sounds for your cell phone.




Mobile AlertTEXT MESSAGE ALERT
Mad Money's mobile. Get show highlights sent to your phone.







Text Size
Mar.04
6:37 PM ET
Wednesday, 4 Mar 2009
Dividends Over Buybacks

Many companies could have better served their shareholders by paying dividends, Cramer said Wednesday, rather than buying back stock. Buybacks no doubt have their place, but some firms have virtually thrown money away in the process, money that should have gone to investors. Not only was stock purchased at much higher prices, but insiders were the people selling. Management made its buck without concern for the shareholders.

Some of the worst offenders operate in the HMO industry, namely Aetna [AET  Loading...      ()   ], WellPoint [WLP  Loading...      ()   ] and UnitedHealth [UNH  Loading...      ()   ]. Aetna pays out a 4-cent, once-a-year dividend, which totaled $59.2 million between 2006 and 2008. But over the same period the company bought back $5.8 billion worth of stock, all while AET’s share price fell more than 50%. Aetna still has $614.2 million set aside in its repurchase authorization, which could be returned to investors in the form of a $1.25-a-share dividend. Add on that 4-cent payout, and Aetna’s yielding a healthy 6%.

WellPoint’s no better. In fact, by one measure it’s worse: The company pays no dividend. So shareholders got nothing while the company spent about $14 billion buying back stock between 2006 and 2009. And over that time, WLP has dropped 60%. If the $820 million in the repurchase authorization were used for a dividend, WLP would offer $1.57 a share, or 4.7%. A sizable dividend such as that would push the stock higher as investors flocked to it for safety, and that would keep the shorts at bay (because they’d be forced to pay the dividend to stay short).

UnitedHealth tells a similar story, with the company spending $11.6 billion on buybacks between 2006 and 2008 as the share price dropped a whopping 71%. Dividend payouts, however, totaled just $118 million.

The moral of the story? This waste of money has done little more than offer a tiny boost to these companies’ earnings per share without actually growing profits. The buybacks reduced the stocks’ floats, to benefit of insiders apparently, but that’s about it. Paying shareholders, on the other hand, could have shown legitimate benefits to Aetna, WellPoint and UnitedHealth, because, historically, 40% of a stock’s return has come from dividends.

So what’s worse, Cramer asked, paying a dividend that could always be cut if necessary, or flushing billions of dollars down the drain buying back a depreciating stock?




Questions for Cramer?

Questions, comments, suggestions for the Mad Money website?

© 2009 CNBC, Inc. All Rights Reserved

Tools:
PrintEmailAdd This share icon
Next Post
  • digg share
ADD COMMENTS
Remaining characters


Current DateTime: 01:19:41 24 Nov 2009
LinksList Documentid: 29778428

Current DateTime: 01:01:05 24 Nov 2009
LinksList Documentid: 29779196

Current DateTime: 01:09:39 24 Nov 2009
LinksList Documentid: 29779199

Current DateTime: 01:01:05 24 Nov 2009
LinksList Documentid: 29779198
  Data is a real-time snapshot  *Data is delayed at least 15 minutes
Global Business and Financial News, Stock Quotes, and Market Data and Analysis

© 2009 CNBC, Inc.  All Rights Reserved.
A Division of NBC Universal
Thomson ReutersThomson Reuters